Dose-dependent effect of angiotensin II on human erythropoietin production

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Pflügers Archiv

• Publication date

  2000-02-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s004249900238PMID 10784360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erythropoietin in 29 men during and after prolonged physical stress combined with food and fluid deprivation

  2004cited by this paper
• Diurnal variations of serum erythropoietin in trained and untrained subjects

  2004cited by this paper
• Erythropoietin production in healthy volunteers subjected to controlled haemorrhage: evidence against a major role for adenosine.

  2003cited by this paper
• Erythropoietin production in healthy volunteers subjected to controlled hypobaric hypoxia: further evidence against a role for adenosine.

  2003influential reference
• Fenoterol stimulates human erythropoietin production via activation of the renin angiotensin system.

  1999cited by this paper
• Angiotensin II increases erythropoietin production in healthy human volunteers

  1999influential reference
• Fenoterol increases erythropoietin concentrations during tocolysis.

  1998cited by this paper
• No influence of aging on the circadian rhythm of erythropoietin in healthy subjects.

  1997cited by this paper
• Effects of angiotensin-II infusion at pressor and subpressor doses on endothelin-1 plasma levels in healthy men.

  1997cited by this paper
• Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis.

  1997cited by this paper
• Angiotensin II stimulates proliferation of normal early erythroid progenitors.

  1997cited by this paper
• Fenoterol but not dobutamine increases erythropoietin production in humans

  1997influential reference
• Posttransplant erythrocytosis: a model for the investigation of the pharmacological control of renal erythropoietin production?

  1996cited by this paper
• Erythropoietin in the control of red cell production.

  1996cited by this paper
• Role of prostaglandins in renal medullary circulation: response to different vasoconstrictors.

  1996cited by this paper
• Renin-angiotensin system stimulates erythropoietin secretion in chronic hemodialysis patients.

  1995cited by this paper
• Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.

  1994cited by this paper
• Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.

  1993cited by this paper
• Renin release induced by losartan (DuP 753), an angiotensin II receptor antagonist.

  1993cited by this paper
• Identification of the renal erythropoietin-producing cells using transgenic mice.

  1993cited by this paper
• Immunocytochemical demonstration of erythropoietin in hypoxic human hepatoma cultures

  1993cited by this paper
• Clinical Applicability of the Determination of Erythropoietin

  1992cited by this paper
• Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers.

  1992cited by this paper
• Circadian rhythm of erythropoietin in human serum

  1989cited by this paper
• Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats.

  1988cited by this paper
• Interrelation of the renin system and erythropoietin in rats.

  1980cited by this paper
• Relationships between blood pressure, age, plasma renin activity and electrolyte excretion in normotensive subjects.

  1977influential reference
• Effect of angiotensin II and an angiotensin II inhibitor on renin secretion in the dog.

  1975cited by this paper
• Renin and angiotensin.

  1968cited by this paper
• Effects of angiotensin and renal artery constriction on erythropoietin production.

  1967cited by this paper

• Angiotensin-converting enzyme and exercise adaptations: Genetic variability, pharmacological modulation and future directions.

  2025cites this paper
• Increased plasma levels of erythropoietin after renal denervation in patients with resistant hypertension

  2025cites this paper
• The role and clinical implications of HIF-PHI daprodustat in dialysis-dependent and non-dialysis-dependent chronic kidney disease anemic patients: a general review

  2024cites this paper
• The Contribution of the AT1 Receptor to Erythropoiesis.

  2023cites this paper
• Anemia as an adaptive phenomenon

  2021cites this paper
• Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents

  2021cites this paper
• Efficacy of telmisartan for the treatment of persistent renal proteinuria in dogs: A double‐masked, randomized clinical trial

  2020cites this paper
• The role of blood volume in cardiac dysfunction and reduced exercise tolerance in patients with diabetes.

  2019cites this paper
• Arterial oxygen content regulates plasma erythropoietin independent of arterial oxygen tension: a blinded crossover study.

  2019cites this paper
• Erythropoietin response to anaemia in heart failure

  2018cites this paper
• The Effects of Altitude Training on Erythropoietic Response and Hematological Variables in Adult Athletes: A Narrative Review

  2018cites this paper
• Recombinant erythropoietin acutely decreases renal perfusion and decouples the renin‐angiotensin‐aldosterone system

  2018cites this paper
• Regulation of Red Blood Cell Volume with Exercise Training.

  2018cites this paper
• Erythropoietin Regulation by Angiotensin II.

  2017cites this paper
• Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hypertension

  2017cites this paper
• PlanHab: Hypoxia counteracts the erythropoietin suppression, but seems to exaggerate the plasma volume reduction induced by 3 weeks of bed rest

  2016cites this paper
• Reduction in central venous pressure enhances erythropoietin synthesis: role of volume‐regulating hormones

  2016cites this paper
• Assessing the Relationship of Angiotensin II Type 1 Receptors with Erythropoietin in a Human Model of Endogenous Angiotensin II Type 1 Receptor Antagonism

  2015cites this paper
• Mechanism of Erythropoietin Regulation by Angiotensin II

  2014cites this paper
• Microsoft Word-Epo_paper second revision 4 1 2014

  2014cites this paper
• Effects of recombinant human erythropoietin in normal humans

  2011cites this paper
• Captopril modulates hypoxia-inducible factors and erythropoietin responses in a murine model of total body irradiation.

  2011cites this paper
• Erythropoietin down‐regulates proximal renal tubular reabsorption and causes a fall in glomerular filtration rate in humans

  2011cites this paper
• Erythropoietin during hypoglycaemia in type 1 diabetes: relation to basal renin-angiotensin system activity and cognitive function.

  2009cites this paper
• Urinary obstruction depresses erythropoiesis which recovers after parenchyma-saving surgery but not SWL

  2009cites this paper
• Iron and anemia in human biology: a review of mechanisms

  2008cites this paper
• Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume

  2007cites this paper
• Congestive heart failure-related anemia and a role for erythropoietin.

  2007cites this paper
• zur Erlangung des Doktorgrades

  2007cites this paper
• Renale Anämie — eine wichtige Folgeerkrankung der Niereninsuffizienz

  2006cites this paper
• Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer

  2006cites this paper
• [Renal anemia - an important secondary disease in renal insufficiency].

  2006cites this paper
• Effect of endothelin-1 on erythropoietin production in a rat model under normoxia and functional carbon monoxide-induced hypoxia

  2006cites this paper
• Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors.

  2006cites this paper
• Role of Renal Nerves and Salt Intake on Erythropoietin Secretion in Rats following Carbon Monoxide Exposure

  2006cites this paper
• Research Erythropoietin and renin as biological markers in critically ill

  2004cites this paper
• Erythropoietin and renin as biological markers in critically ill patients

  2004cites this paper
• Does Angiotensin II Modulate Erythropoietin Production in HepG2 Cells?

  2004cites this paper
• Regulation der Erythropoetin-Sekretion: Einfluss des endogenen Angiotensins unter salzarmer und salzreicher Ernährung

  2004cites this paper
• The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, and the influence of ACE genotype

  2004cites this paper
• Progression of renal failure with anaemia and multiple effects of angiotensin-converting enzyme inhibitor in rats with renal mass reduction.

  2003cites this paper
• Effect of angiotensin II and angiotensin(1–7) on hematopoietic recovery after intravenous chemotherapy

  2003cites this paper
• Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans?

  2003cites this paper
• Influence of controlled hypoxia and radical scavenging agents on erythropoietin and malondialdehyde concentrations in humans.

  2002cites this paper
• Protection against ischemia: a physiological function of the renin-angiotensin system.

  2001cites this paper
• World Journal of Experimental Medicine

  year unknowncites this paper